Treatments in Endocrinology

, Volume 2, Issue 2, pp 95–108 | Cite as

Diabetic Ketoacidosis

Risk Factors and Management Strategies
  • Guillermo E. Umpierrez
  • Abbas E. Kitabchi
Therapy in Practice


Diabetic ketoacidosis (DKA) is the most common hyperglycemic emergency in patients with diabetes mellitus. DKA most often occurs in patients with type 1 diabetes, but patients with type 2 diabetes are susceptible to DKA under stressful conditions, such as trauma, surgery, or infections. DKA is reported to be responsible for more than 100 000 hospital admissions per year in the US, and accounts for 4–9% of all hospital discharge summaries among patients with diabetes. Treatment of patients with DKA uses significant healthcare resources and accounts for 1 out of every 4 healthcare dollars spent on direct medical care for adult patients with type 1 diabetes in the US.

Recent studies using standardized written guidelines for therapy have demonstrated a mortality rate of less than 5%, with higher mortality rates observed in elderly patients and those with concomitant life-threatening illnesses. Worldwide, infection is the most common precipitating cause for DKA, occurring in 30–50% of cases. Urinary tract infection and pneumonia account for the majority of infections. Other precipitating causes are intercurrent illnesses (i.e., surgery, trauma, myocardial ischemia, pancreatitis), psychological stress, and non-compliance with insulin therapy. The triad of uncontrolled hyperglycemia, metabolic acidosis and increased total body ketone concentration characterizes DKA. These metabolic derangements result from the combination of absolute or relative insulin deficiency and increased levels of counter-regulatory hormones (glucagon, catecholamines, cortisol, and growth hormone).

Successful treatment of DKA requires frequent monitoring of patients, correction of hypovolemia and hyperglycemia, replacement of electrolyte losses, and careful search for the precipitating cause. Since the majority of DKA cases occur in patients with a known history of diabetes, this acute metabolic complication should be largely preventable through early detection, and by the education of patients, healthcare professionals, and the general public.

The frequency of hospitalizations for DKA has been reduced following diabetes education programs, improved follow-up care, and access to medical advice. Novel approaches to patient education incorporating a variety of healthcare beliefs and socioeconomic issues are critical to an effective prevention program.


Ketone Body Insulin Aspart Insulin Lispro Continuous Subcutaneous Insulin Infusion Serum Potassium Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Kaufman FR, Halvorson M. The treatment and prevention of diabetic ketoacidosis in children and adolescents with type I diabetes mellitus. Pediatr Ann 1999; 28: 576–82PubMedGoogle Scholar
  2. 2.
    Graves EJ, Gillium BS. Detailed diagnosis and procedures: National Discharge Survey, 1995. National Center for Health Statistics. Vital Health Stat 13 1997; 130: 133Google Scholar
  3. 3.
    Johnson DD, Palumbo PJ, Chu CP. Diabetic ketoacidosis in a community-based population. Mayo Clin Proc 1980; 55: 83–8PubMedGoogle Scholar
  4. 4.
    Faich GA, Fishbein HA, Ellis SE. The epidemiology of diabetic acidosis: a population-based study. Am J Epidemiol 1983; 117: 551–8PubMedGoogle Scholar
  5. 5.
    Umpierrez GE, Casals MM, Gebhart SP, et al. Diabetic ketoacidosis in obese African-Americans. Diabetes 1995; 44: 790–5PubMedCrossRefGoogle Scholar
  6. 6.
    Umpierrez GE, Woo W, Hagopian WA, et al. Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care 1999; 22: 1517–23PubMedCrossRefGoogle Scholar
  7. 7.
    Balasubramanyam A, Zern JW, Hyman DJ, et al. New profiles of diabetic ketoacidosis: type 1 vs type 2 diabetes and the effect of ethnicity. Arch Intern Med 1999; 159: 2317–22PubMedCrossRefGoogle Scholar
  8. 8.
    McFarlane SI, Chaiken RL, Hirsch S, et al. Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function. Diabet Med 2001; 18: 10–6PubMedCrossRefGoogle Scholar
  9. 9.
    Centers for Disease Control, Division of Diabetes Translations. Diabetes Surveillance, 1991. Washington, DC: US Government Printing Office, 1992: 635–1150Google Scholar
  10. 10.
    Fishbein HA. Diabetic ketoacidosis, hyperosmolar nonketotic coma, lactic acidosis and hypoglycemia. In: Harris MI, Hamman RF, editors. Diabetes in America (National Diabetes Group). Washington, DC: US Department of Health and Human Sciences, 1985: XII–1–16Google Scholar
  11. 11.
    Geiss LS, Herman WH, Goldschmid MG, et al. Surveillance for diabetes mellitus: United States, 1980–1989. MMWR CDC Surveill Summ 1993; 42: 1–20PubMedGoogle Scholar
  12. 12.
    Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 1994; 37: 278–85CrossRefGoogle Scholar
  13. 13.
    Ellemann K, Soerensen JN, Pedersen L, et al. Epidemiology and treatment of diabetic ketoacidosis in a community population. Diabetes Care 1984; 7: 528–32PubMedCrossRefGoogle Scholar
  14. 14.
    Wright AD, Hale PJ, Singh BM, et al. Changing sex ratio in diabetic ketoacidosis. Diabet Med 1990; 7: 628–32PubMedCrossRefGoogle Scholar
  15. 15.
    Umpierrez GE, Kelly JP, Navarrete JE, et al. Hyperglycemic crises in urban blacks. Arch Intern Med 1997; 157: 669–75PubMedCrossRefGoogle Scholar
  16. 16.
    Javor KA, Kotsanos JG, McDonald RC, et al. Diabetic ketoacidosis charges relative to medical charges of adult patients with type I diabetes. Diabetes Care 1997; 20: 349–54PubMedCrossRefGoogle Scholar
  17. 17.
    Kitabchi AE, Umpierrez GE, Murphy MB, et al. Management of hyperglycemic crises in patients with diabetes. Diabetes Care 2001; 24: 131–53PubMedCrossRefGoogle Scholar
  18. 18.
    Moss JM. Diabetic ketoacidosis: effective low-cost treatment in a community hospital. South Med J 1987; 80: 875–81PubMedCrossRefGoogle Scholar
  19. 19.
    Wagner A, Risse A, Brill HL, et al. Therapy of severe diabetic ketoacidosis: zero-mortality under very-low-dose insulin application. Diabetes Care 1999; 22(5): 674–7PubMedCrossRefGoogle Scholar
  20. 20.
    White NH. Diabetic ketoacidosis in children. Endocrinol Metab Clin North Am 2000; 29: 657–82PubMedCrossRefGoogle Scholar
  21. 21.
    Basu A, Close CF, Jenkins D, et al. Persisting mortality in diabetic ketoacidosis. Diabet Med 1993; 10: 282–4PubMedCrossRefGoogle Scholar
  22. 22.
    Malone ML, Gennis V, Goodwin JS. Characteristics of diabetic ketoacidosis in older versus younger adults. J Am Geriatr Soc 1992; 40: 1100–4PubMedGoogle Scholar
  23. 23.
    Scibilia J, Finegold D, Dorman J, et al. Why do children with diabetes die? Acta Endocrinol Suppl (Copenh) 1986; 279: 326–33Google Scholar
  24. 24.
    Umpierrez GE, Khajavi M, Kitabchi AE. Review: diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic syndrome. Am J Med Sci 1996; 311: 225–33PubMedCrossRefGoogle Scholar
  25. 25.
    Rwiza HT, Swai AB, McLarty DG. Failure to diagnose diabetic ketoacidosis in Tanzania. Diabet Med 1986; 3: 181–3PubMedCrossRefGoogle Scholar
  26. 26.
    Polonsky WH, Anderson BJ, Lohrer PA, et al. Insulin omission in women with IDDM. Diabetes Care 1994; 17: 1178–85PubMedCrossRefGoogle Scholar
  27. 27.
    Rydall AC, Rodin GM, Olmsted MP, et al. Disordered eating behavior and microvascular complications in young women with insulin-dependent diabetes mellitus. N Engl J Med 1997; 336: 1849–54PubMedCrossRefGoogle Scholar
  28. 28.
    Musey VC, Lee JK, Crawford R, et al. Diabetes in urban African-Americans: I. Cessation of insulin therapy is the major precipitating cause of diabetic ketoacidosis. Diabetes Care 1995; 18: 483–9PubMedCrossRefGoogle Scholar
  29. 29.
    Teutsch SM, Herman WH, Dwyer DM, et al. Mortality among diabetic patients using continuous subcutaneous insulin-infusion pumps. N Engl J Med 1984; 310: 361–8PubMedCrossRefGoogle Scholar
  30. 30.
    Bending JJ, Pickup JC, Keen H. Frequency of diabetic ketoacidosis and hypoglycemic coma during treatment with continuous subcutaneous insulin infusion: audit of medical care. Am J Med 1985; 79: 685–91PubMedCrossRefGoogle Scholar
  31. 31.
    Siperstein MD. Diabetic ketoacidosis and hyperosmolar coma. Endocrinol Metab Clin North Am 1992; 21: 415–32PubMedGoogle Scholar
  32. 32.
    Delaney MF, Zisman A, Kettyle WM. Diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic syndrome. Endocrinol Metab Clin North Am 2000; 29: 683–705PubMedCrossRefGoogle Scholar
  33. 33.
    Kitabchi AE, Wall BM. Diabetic ketoacidosis. Med Clin North Am 1995; 79: 9–37PubMedGoogle Scholar
  34. 34.
    Merimee TJ, Tyson JE. Stabilization of plasma glucose during fasting: normal variations in two separate studies. N Engl J Med 1974; 291: 1275–8PubMedCrossRefGoogle Scholar
  35. 35.
    DeFronzo RA, Matzuda M, Barret E. Diabetic ketoacidosis: a combined metabolic-nephrologic approach to therapy. Diabetes Rev 1994; 2: 209–38Google Scholar
  36. 36.
    Felig P, Sherwin RS, Soman V, et al. Hormonal interactions in the regulation of blood glucose. Recent Prog Horm Res 1979; 35: 501–32PubMedGoogle Scholar
  37. 37.
    Gerich JE, Lorenzi M, Bier DM, et al. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism: studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin. J Clin Invest 1976; 57: 875–84PubMedCrossRefGoogle Scholar
  38. 38.
    McGarry JD, Woeltje KF, Kuwajima M, et al. Regulation of ketogenesis and the renaissance of carnitine palmitoyltransferase. Diabetes Metab Rev 1989; 5: 271–84PubMedCrossRefGoogle Scholar
  39. 39.
    Foster DW, McGarry JD. The metabolic derangements and treatment of diabetic ketoacidosis. N Engl J Med 1983; 309: 159–69PubMedCrossRefGoogle Scholar
  40. 40.
    van de Werve G, Jeanrenaud B. Liver glycogen metabolism: an overview. Diabetes Metab Rev 1987; 3: 47–78PubMedCrossRefGoogle Scholar
  41. 41.
    Exton JH. Mechanisms of hormonal regulation of hepatic glucose metabolism. Diabetes Metab Rev 1987; 3: 163–83PubMedCrossRefGoogle Scholar
  42. 42.
    Robertson RP, Olson LK, Zhang HJ. Differentiating glucose toxicity from glucose desensitization: a new message from the insulin gene. Diabetes 1994; 43(9): 1085–9PubMedCrossRefGoogle Scholar
  43. 43.
    Rossetti L, Giaccari A, DeFronzo RA. Glucose toxicity. Diabetes Care 1990; 13: 610–30PubMedCrossRefGoogle Scholar
  44. 44.
    Yki-Jarvinen H. Glucose toxicity. Endocr Rev 1992; 13: 415–31PubMedGoogle Scholar
  45. 45.
    Giddings SJ, Chirgwin J, Permutt MA. Effects of glucose on proinsulin messenger RNA in rats in vivo. Diabetes 1982; 31: 624–9PubMedCrossRefGoogle Scholar
  46. 46.
    Leibowitz G, Melloul D, Yuli M, et al. Defective glucose-regulated insulin gene expression associated with PDX-1 deficiency in the Psammomys obesus model of type 2 diabetes. Diabetes 2001; 50Suppl. 1: S138–9PubMedCrossRefGoogle Scholar
  47. 47.
    McGarry JD. Lilly Lecture 1978: new perspectives in the regulation of ketogenesis. Diabetes 1979; 28: 517–23PubMedGoogle Scholar
  48. 48.
    McGarry JD, Foster DW. Regulation of hepatic fatty acid oxidation and ketone body production. Annu Rev Biochem 1980; 49: 395–420PubMedCrossRefGoogle Scholar
  49. 49.
    Cook GA, King MT, Veech RL. Ketogenesis and malonyl coenzyme A content of isolated rat hepatocytes. J Biol Chem 1978; 253: 2529–31PubMedGoogle Scholar
  50. 50.
    Miles JM, Rizza RA, Haymond MW, et al. Effects of acute insulin deficiency on glucose and ketone body turnover in man: evidence for the primacy of overproduction of glucose and ketone bodies in the genesis of diabetic ketoacidosis. Diabetes 1980; 29: 926–30PubMedGoogle Scholar
  51. 51.
    Reichard GA, Skutches CL, Hoeldtke RD, et al. Acetone metabolism in humans during diabetic ketoacidosis. Diabetes 1986; 35: 668–74PubMedCrossRefGoogle Scholar
  52. 52.
    Campbell IW, Duncan LJ, Innes JA, et al. Abdominal pain in diabetic metabolic decompensation: clinical significance. JAMA 1975; 233: 166–8PubMedCrossRefGoogle Scholar
  53. 53.
    Fraser RJ, Horowitz M, Maddox AF, et al. Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1990; 33: 675–80PubMedCrossRefGoogle Scholar
  54. 54.
    de Boer SY, Masclee AA, Lam WF, et al. Effect of hyperglycaemia on gallbladder motility in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1994; 37: 75–81PubMedCrossRefGoogle Scholar
  55. 55.
    Umpierrez G, Freire AX. Abdominal pain in patients with hyperglycemic crises. J Crit Care 2002; 17: 63–7PubMedCrossRefGoogle Scholar
  56. 56.
    Jenkins D, Close CF, Krentz AJ, et al. Euglycaemic diabetic ketoacidosis: does it exist? Acta Diabetol 1993; 30: 251–3PubMedCrossRefGoogle Scholar
  57. 57.
    Munro JF, Campbell IW, McCuish AC, et al. Euglycaemic diabetic ketoacidosis. BMJ 1973; 2: 578–80PubMedCrossRefGoogle Scholar
  58. 58.
    Stephens JM, Sulway MJ, Watkins PJ. Relationship of blood acetoacetate and 3-hydroxybutyrate in diabetes. Diabetes 1971; 20: 485–9PubMedGoogle Scholar
  59. 59.
    Byrne HA, Tieszen KL, Hollis S, et al. Evaluation of an electrochemical sensor for measuring blood ketones. Diabetes Care 2000; 23: 500–3PubMedCrossRefGoogle Scholar
  60. 60.
    Alberti KG, Hockaday TD. Rapid blood ketone body estimation in the diagnosis of diabetic ketoacidosis. BMJ 1972; 2: 565–8PubMedCrossRefGoogle Scholar
  61. 61.
    Umpierrez GE, DiGirolamo M, Tuvlin JA, et al. Differences in metabolic and hormonal milieu in diabetic- and alcohol-induced ketoacidosis. J Crit Care 2000; 15: 52–9PubMedCrossRefGoogle Scholar
  62. 62.
    Umpierrez GE, Watts NB, Phillips LS. Clinical utility of beta-hydroxybutyrate determined by reflectance meter in the management of diabetic ketoacidosis. Diabetes Care 1995; 18: 137–8PubMedGoogle Scholar
  63. 63.
    Winter SD, Pearson JR, Gabow PA, et al. The fall of the serum anion gap. Arch Intern Med 1990; 150: 311–3PubMedCrossRefGoogle Scholar
  64. 64.
    Adrogue HJ, Wilson H, Boyd AE, et al. Plasma acid-base patterns in diabetic ketoacidosis. N Engl J Med 1982; 307: 1603–10PubMedCrossRefGoogle Scholar
  65. 65.
    Adrogue HJ, Eknoyan G, Suki WK. Diabetic ketoacidosis: role of the kidney in the acid-base homeostasis re-evaluated. Kidney Int 1984; 25: 591–8PubMedCrossRefGoogle Scholar
  66. 66.
    Kaminska ES, Pourmotabbed G. Spurious laboratory values in diabetic ketoacidosis and hyperlipidemia. Am J Emerg Med 1993; 11: 77–80PubMedCrossRefGoogle Scholar
  67. 67.
    Adrogue HJ, Lederer ED, Suki WN, et al. Determinants of plasma potassium levels in diabetic ketoacidosis. Medicine (Baltimore) 1986; 65: 163–72Google Scholar
  68. 68.
    Lebovitz HE. Diabetic ketoacidosis. Lancet 1995; 345: 767–72PubMedCrossRefGoogle Scholar
  69. 69.
    Slovis CM, Mork VG, Slovis RJ, et al. Diabetic ketoacidosis and infection: leukocyte count and differential as early predictors of serious infection. Am J Emerg Med 1987; 5: 1–5PubMedCrossRefGoogle Scholar
  70. 70.
    VinicorF, Lehrner LM, Karn RC, et al. Hyperamylasemia in diabetic ketoacidosis: sources and significance. Ann Intern Med 1979; 91: 200–4Google Scholar
  71. 71.
    Vantyghem MC, Haye S, Balduyck M, et al. Changes in serum amylase, lipase and leukocyte elastase during diabetic ketoacidosis and poorly controlled diabetes. Acta Diabetol 1999; 36: 39–44PubMedCrossRefGoogle Scholar
  72. 72.
    Yadav D, Nair S, Norkus EP, et al. Nonspecific hyperamylasemia and hyper-lipasemia in diabetic ketoacidosis: incidence and correlation with biochemical abnormalities. Am J Gastroenterol 2000; 95: 3123–8PubMedCrossRefGoogle Scholar
  73. 73.
    Nair S, Yadav D, Pitchumoni CS. Association of diabetic ketoacidosis and acute pancreatitis: observations in 100 consecutive episodes of DKA. Am J Gastroenterol 2000; 95: 2795–800PubMedCrossRefGoogle Scholar
  74. 74.
    Wrenn KD, Slovis CM, Minion GE, et al. The syndrome of alcoholic ketoacidosis. Am J Med 1991; 91: 119–28PubMedCrossRefGoogle Scholar
  75. 75.
    Bleich HL, Boro ES. Metabolic and hepatic effects of alcohol. N Engl J Med 1977; 296: 612–6PubMedCrossRefGoogle Scholar
  76. 76.
    Cahill GF. Ketosis. Kidney Int 1981; 20: 416–25PubMedCrossRefGoogle Scholar
  77. 77.
    Barrett EJ, DeFronzo RA. Diabetic ketoacidosis: diagnosis and treatment. Hosp Pract (Off Ed) 1984; 19: 89–104Google Scholar
  78. 78.
    Cahill GF. Starvation in man. N Engl J Med 1970; 282: 668–75PubMedCrossRefGoogle Scholar
  79. 79.
    May ME, Young C, King J. Resource utilization in treatment of diabetic ketoacidosis in adults. Am J Med Sci 1993; 306: 287–94PubMedCrossRefGoogle Scholar
  80. 80.
    Waldhausl W, Kleinberger G, Korn A, et al. Severe hyperglycemia: effects of rehydration on endocrine derangements and blood glucose concentration. Diabetes 1979; 28: 577–84PubMedGoogle Scholar
  81. 81.
    Owen OE, Licht JH, Sapir DG. Renal function and effects of partial rehydration during diabetic ketoacidosis. Diabetes 1981; 30: 510–8PubMedGoogle Scholar
  82. 82.
    Kitabchi AE, Fisher JN, Murphy MB, Rumbak MJ. Diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic state. In: Hahn CR, Weir GC, editors. Joslin’s diabetes mellitus. 13th ed. Philadelphia (PA): Lea & Febiger, 1994: 738–770Google Scholar
  83. 83.
    Pinies JA, Cairo G, Gaztambide S, et al. Course and prognosis of 132 patients with diabetic non ketotic hyperosmolar state. Diabete Metab 1994; 20: 43–8PubMedGoogle Scholar
  84. 84.
    Hillman K. Fluid resuscitation in diabetic emergencies: a reappraisal. Intensive Care Med 1987; 13: 4–8PubMedCrossRefGoogle Scholar
  85. 85.
    Alberti KG, Hockaday TD, Turner RC. Small doses of intramuscular insulin in the treatment of diabetic “coma”. Lancet 1973; II: 515–22CrossRefGoogle Scholar
  86. 86.
    Burghen GA, Etteldorf JN, Fisher JN, et al. Comparison of high-dose and lowdose insulin by continuous intravenous infusion in the treatment of diabetic ketoacidosis in children. Diabetes Care 1980; 3: 15–20PubMedCrossRefGoogle Scholar
  87. 87.
    Fisher JN, Shahshahani MN, Kitabchi AE. Diabetic ketoacidosis: low-dose insulin therapy by various routes. N Engl J Med 1977; 297: 238–41PubMedCrossRefGoogle Scholar
  88. 88.
    Page MM, Alberti KG, Greenwood R, et al. Treatment of diabetic coma with continuous low-dose infusion of insulin. BMJ 1974; 2: 687–90PubMedCrossRefGoogle Scholar
  89. 89.
    Luzi L, Barrett EJ, Groop LC, et al. Metabolic effects of low-dose insulin therapy on glucose metabolism in diabetic ketoacidosis. Diabetes 1988; 37: 1470–7PubMedCrossRefGoogle Scholar
  90. 90.
    Sacks HS, Shahshahani M, Kitabchi AE, et al. Similar responsiveness of diabetic ketoacidosis to low-dose insulin by intramuscular injection and albumin-free infusion. Ann Intern Med 1979; 90: 36–42PubMedGoogle Scholar
  91. 91.
    Latif K, Umpierrez GE, Stoever J, et al. Subcutaneous lispro insulin in the treatment of diabetic ketoacidosis [abstract]. Diabetes 2002; 51Suppl. 2: A427Google Scholar
  92. 92.
    Abramson E, Arky R. Diabetic acidosis with initial hypokalemia: therapeutic implications. JAMA 1966; 196: 401–3PubMedCrossRefGoogle Scholar
  93. 93.
    McCurdy DK. Hyperosmolar hyperglycemic nonketotic diabetic coma. Med Clin North Am 1970; 54: 683–99PubMedGoogle Scholar
  94. 94.
    DeFronzo RA, Felig P, Ferrannini E, et al. Effect of graded doses of insulin on splanchnic and peripheral potassium metabolism in man. Am J Physiol 1980; 238: E421–7PubMedGoogle Scholar
  95. 95.
    Mitchell JH, Wildenthal K, Johnson RL. The effects of acid-base disturbances on cardiovascular and pulmonary function. Kidney Int 1972; 1: 375–89PubMedCrossRefGoogle Scholar
  96. 96.
    Housley E, Clarke SW, Hedworth-Whitty RB, et al. Effect of acute and chronic acidaemia and associated hypoxia on the pulmonary circulation of patients with chronic bronchitis. Cardiovasc Res 1970; 4: 482–9PubMedCrossRefGoogle Scholar
  97. 97.
    Soler NG, Bennett MA, Dixon K, et al. Potassium balance during treatment of diabetic ketoacidosis with special reference to the use of bicarbonate. Lancet 1972; II: 665–7CrossRefGoogle Scholar
  98. 98.
    Morris LR, Murphy MB, Kitabchi AE. Bicarbonate therapy in severe diabetic ketoacidosis. Ann Intern Med 1986; 105: 836–40PubMedGoogle Scholar
  99. 99.
    Lever E, Jaspan JB. Sodium bicarbonate therapy in severe diabetic ketoacidosis. Am J Med 1983; 75: 263–8PubMedCrossRefGoogle Scholar
  100. 100.
    Fisher JN, Kitabchi AE. A randomized study of phosphate therapy in the treatment of diabetic ketoacidosis. J Clin Endocrinol Metab 1983; 57: 177–80PubMedCrossRefGoogle Scholar
  101. 101.
    Wilson HK, Keuer SP, Lea AS, et al. Phosphate therapy in diabetic ketoacidosis. Arch Intern Med 1982; 142: 517–20PubMedCrossRefGoogle Scholar
  102. 102.
    Winter RJ, Harris CJ, Phillips LS, et al. Diabetic ketoacidosis: induction of hypocalcemia and hypomagnesemia by phosphate therapy. Am J Med 1979; 67: 897–900PubMedCrossRefGoogle Scholar
  103. 103.
    Alberti KG, Emerson PM, Darley JH, et al. 2,3-Diphosphoglycerate and tissue oxygenation in uncontrolled diabetes mellitus. Lancet 1972; II: 391–5CrossRefGoogle Scholar
  104. 104.
    Gibby OM, Veale KE, Hayes TM, et al. Oxygen availability from the blood and the effect of phosphate replacement on erythrocyte 2,3-diphosphoglycerate and haemoglobin: oxygen affinity in diabetic ketoacidosis. Diabetologia 1978; 15: 381–5PubMedCrossRefGoogle Scholar
  105. 105.
    Kreisberg RA. Phosphorus deficiency and hypophosphatemia. Hosp Pract 1977; 12: 121–8PubMedGoogle Scholar
  106. 106.
    Kreisberg RA. Diabetic ketoacidosis: an update. Crit Care Clin 1987; 3: 817–34PubMedGoogle Scholar
  107. 107.
    Rattarasarn C, Dagogo-Jack S, Zachwieja JJ, et al. Hypoglycemia-induced autonomic failure in IDDM is specific for stimulus of hypoglycemia and is not attributable to prior autonomic activation. Diabetes 1994; 43: 809–18PubMedCrossRefGoogle Scholar
  108. 108.
    Bello FA, Sotos JF. Cerebral oedema in diabetic ketoacidosis in children [letter]. Lancet 1990; 336: 64PubMedCrossRefGoogle Scholar
  109. 109.
    Duck SC, Wyatt DT. Factors associated with brain herniation in the treatment of diabetic ketoacidosis. J Pediatr 1988; 113: 10–4PubMedCrossRefGoogle Scholar
  110. 110.
    Rosenbloom AL. Intracerebral crises during treatment of diabetic ketoacidosis. Diabetes Care 1990; 13: 22–33PubMedCrossRefGoogle Scholar
  111. 111.
    Glaser N, Barnett P, McCaslin I, et al. Risk factors for cerebral edema in children with diabetic ketoacidosis: the Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. N Engl J Med 2001; 344: 264–9PubMedCrossRefGoogle Scholar
  112. 112.
    Silver SM, Clark EC, Schroeder BM, et al. Pathogenesis of cerebral edema after treatment of diabetic ketoacidosis. Kidney Int 1997; 51: 1237–44PubMedCrossRefGoogle Scholar
  113. 113.
    Lorber D. Non-ketotic hypertonicity in diabetes. Endocrinologist 1993; 3: 29–38CrossRefGoogle Scholar
  114. 114.
    Beech JS, Williams SR, Cohen RD, et al. Gluconeogenesis and the protection of hepatic intracellular pH during diabetic ketoacidosis in rats. Biochem J 1989; 263: 737–44PubMedGoogle Scholar
  115. 115.
    Paton RC. Haemostatic changes in diabetic coma. Diabetologia 1981; 21: 172–7PubMedCrossRefGoogle Scholar
  116. 116.
    Hamblin PS, Topliss DJ, Chosich N, et al. Deaths associated with diabetic ketoacidosis and hyperosmolar coma 1973–1988. Med J Aust 1989; 151: 439–44PubMedGoogle Scholar
  117. 117.
    Buyukasik Y, Ileri NS, Haznedaroglu IC, et al. Enhanced subclinical coagulation activation during diabetic ketoacidosis. Diabetes Care 1998; 21: 868–70PubMedGoogle Scholar
  118. 118.
    Faigel DO, Metz DC. Prevalence, etiology, and prognostic significance of upper gastrointestinal hemorrhage in diabetic ketoacidosis. Dig Dis Sci 1996; 41: 1–8PubMedCrossRefGoogle Scholar
  119. 119.
    Wang LM, Tsai ST, Ho LT, et al. Rhabdomyolysis in diabetic emergencies. Diabetes Res Clin Pract 1994; 26: 209–14PubMedCrossRefGoogle Scholar
  120. 120.
    Umpierrez GE, Murphy MB, Kitabchi AE. Diabetic ketoacidosis and hyperglycmic hyperosmolar syndrome. Diabetes Spectrum 2002; 15: 28–36CrossRefGoogle Scholar
  121. 121.
    Laffel LM, Brackett J, Ho J, et al. Changing the process of diabetes care improves metabolic outcomes and reduces hospitalizations. Qual Manag Health Care 1998; 6: 53–62PubMedGoogle Scholar
  122. 122.
    Laffel L. Sick-day management in type 1 diabetes. Endocrinol Metab Clin North Am 2000; 29: 707–23PubMedCrossRefGoogle Scholar
  123. 123.
    MacGillivray MH, Li PK, Lee JT, et al. Elevated plasma beta-hydroxybutyrate concentrations without ketonuria in healthy insulin-dependent diabetic patients. J Clin Endocrinol Metab 1982; 54: 665–8PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2003

Authors and Affiliations

  • Guillermo E. Umpierrez
    • 1
  • Abbas E. Kitabchi
    • 1
  1. 1.Department of MedicineUniversity of Tennessee Health Science CenterMemphisUSA

Personalised recommendations